A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments G-CSF proliferation activity but not through the MAP kinase cascade

Toshihiro Yokoyama, Seiichi Okamura, Yoshinobu Asano, Kenjiro Kamezaki, Akihiko Numata, Haruko Kakumitsu, Koutarou Shide, Hitoshi Nakashima, Taisuke Kanaji, Yuichi Sekine, Yumi Mizuno, Jun Okamura, Tadashi Matsuda, Mine Harada, Yoshiyuki Niho, Kazuya Shimoda

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We analyzed the structure of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a 6-year-old female patient with severe congenital neutropenia (SCN) who experienced severe recurrent infections since 1 month of age. There is no family history of any similar disease. When the patient was 4 months old, she began receiving treatment with recombinant human G-CSF that resulted in a small increase in the neutrophil count sufficient for the prevention and treatment of bacterial infection. An analysis of complementary DNA for the patient's G-CSF receptor revealed a 3-base pair deletion in the juxtamembrane intracellular sequence. This deletion at the beginning of exon 16 was thought to be caused by alternative splicing; analysis of the DNA revealed a G-to-A point mutation of the final nucleotide of intron 15. To evaluate the functional activity of the G-CSF receptor with this 3-base pair deletion of the juxtamembrane region, we transfected this G-CSF receptor mutant into an interleukin 3-dependent cell line, BAF/3. BAF/3 cells expressing the mutant G-CSF receptor showed augmented proliferation activity in response to G-CSF compared with cells having the wild-type G-CSF receptor. Although the proliferation signal of G-CSF in normal hematopoiesis is transduced through the activation of MAP kinases, this G-CSF receptor mutant showed decreased activation of ERK1/2 in response to G-CSF compared with the wild type, but the transduced signal for Stat3 activation by G-CSF was of the same magnitude as that of the wild-type G-CSF receptor. This result means that the augmented proliferation activity in response to G-CSF that we observed in cells having the G-CSF receptor gene with the 3-base pair deletion is transduced through an intracellular signaling pathway other than MAP kinase. Because SCN patients with a mutation in the G-CSF receptor frequently develop leukemia, this 3-base pair deletion in the juxtamembrane sequence of the G-CSF receptor gene in this patient may be one step in the course of leukemic transformation.

Original languageEnglish
Pages (from-to)28-34
Number of pages7
JournalInternational journal of hematology
Volume82
Issue number1
DOIs
Publication statusPublished - Jul 1 2005

Fingerprint

Granulocyte Colony-Stimulating Factor Receptors
MAP Kinase Signaling System
Granulocyte Colony-Stimulating Factor
Mutation
Genes
Base Pairing
Neutropenia, Severe Congenital, Autosomal Recessive 3
Interleukin-3
Hematopoiesis
Alternative Splicing
Point Mutation
Bacterial Infections
Introns
Exons

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments G-CSF proliferation activity but not through the MAP kinase cascade. / Yokoyama, Toshihiro; Okamura, Seiichi; Asano, Yoshinobu; Kamezaki, Kenjiro; Numata, Akihiko; Kakumitsu, Haruko; Shide, Koutarou; Nakashima, Hitoshi; Kanaji, Taisuke; Sekine, Yuichi; Mizuno, Yumi; Okamura, Jun; Matsuda, Tadashi; Harada, Mine; Niho, Yoshiyuki; Shimoda, Kazuya.

In: International journal of hematology, Vol. 82, No. 1, 01.07.2005, p. 28-34.

Research output: Contribution to journalArticle

Yokoyama, Toshihiro ; Okamura, Seiichi ; Asano, Yoshinobu ; Kamezaki, Kenjiro ; Numata, Akihiko ; Kakumitsu, Haruko ; Shide, Koutarou ; Nakashima, Hitoshi ; Kanaji, Taisuke ; Sekine, Yuichi ; Mizuno, Yumi ; Okamura, Jun ; Matsuda, Tadashi ; Harada, Mine ; Niho, Yoshiyuki ; Shimoda, Kazuya. / A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments G-CSF proliferation activity but not through the MAP kinase cascade. In: International journal of hematology. 2005 ; Vol. 82, No. 1. pp. 28-34.
@article{2a10a1e8cd5b4cdbacd56ec44895887e,
title = "A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments G-CSF proliferation activity but not through the MAP kinase cascade",
abstract = "We analyzed the structure of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a 6-year-old female patient with severe congenital neutropenia (SCN) who experienced severe recurrent infections since 1 month of age. There is no family history of any similar disease. When the patient was 4 months old, she began receiving treatment with recombinant human G-CSF that resulted in a small increase in the neutrophil count sufficient for the prevention and treatment of bacterial infection. An analysis of complementary DNA for the patient's G-CSF receptor revealed a 3-base pair deletion in the juxtamembrane intracellular sequence. This deletion at the beginning of exon 16 was thought to be caused by alternative splicing; analysis of the DNA revealed a G-to-A point mutation of the final nucleotide of intron 15. To evaluate the functional activity of the G-CSF receptor with this 3-base pair deletion of the juxtamembrane region, we transfected this G-CSF receptor mutant into an interleukin 3-dependent cell line, BAF/3. BAF/3 cells expressing the mutant G-CSF receptor showed augmented proliferation activity in response to G-CSF compared with cells having the wild-type G-CSF receptor. Although the proliferation signal of G-CSF in normal hematopoiesis is transduced through the activation of MAP kinases, this G-CSF receptor mutant showed decreased activation of ERK1/2 in response to G-CSF compared with the wild type, but the transduced signal for Stat3 activation by G-CSF was of the same magnitude as that of the wild-type G-CSF receptor. This result means that the augmented proliferation activity in response to G-CSF that we observed in cells having the G-CSF receptor gene with the 3-base pair deletion is transduced through an intracellular signaling pathway other than MAP kinase. Because SCN patients with a mutation in the G-CSF receptor frequently develop leukemia, this 3-base pair deletion in the juxtamembrane sequence of the G-CSF receptor gene in this patient may be one step in the course of leukemic transformation.",
author = "Toshihiro Yokoyama and Seiichi Okamura and Yoshinobu Asano and Kenjiro Kamezaki and Akihiko Numata and Haruko Kakumitsu and Koutarou Shide and Hitoshi Nakashima and Taisuke Kanaji and Yuichi Sekine and Yumi Mizuno and Jun Okamura and Tadashi Matsuda and Mine Harada and Yoshiyuki Niho and Kazuya Shimoda",
year = "2005",
month = "7",
day = "1",
doi = "10.1532/IJH97.05010",
language = "English",
volume = "82",
pages = "28--34",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments G-CSF proliferation activity but not through the MAP kinase cascade

AU - Yokoyama, Toshihiro

AU - Okamura, Seiichi

AU - Asano, Yoshinobu

AU - Kamezaki, Kenjiro

AU - Numata, Akihiko

AU - Kakumitsu, Haruko

AU - Shide, Koutarou

AU - Nakashima, Hitoshi

AU - Kanaji, Taisuke

AU - Sekine, Yuichi

AU - Mizuno, Yumi

AU - Okamura, Jun

AU - Matsuda, Tadashi

AU - Harada, Mine

AU - Niho, Yoshiyuki

AU - Shimoda, Kazuya

PY - 2005/7/1

Y1 - 2005/7/1

N2 - We analyzed the structure of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a 6-year-old female patient with severe congenital neutropenia (SCN) who experienced severe recurrent infections since 1 month of age. There is no family history of any similar disease. When the patient was 4 months old, she began receiving treatment with recombinant human G-CSF that resulted in a small increase in the neutrophil count sufficient for the prevention and treatment of bacterial infection. An analysis of complementary DNA for the patient's G-CSF receptor revealed a 3-base pair deletion in the juxtamembrane intracellular sequence. This deletion at the beginning of exon 16 was thought to be caused by alternative splicing; analysis of the DNA revealed a G-to-A point mutation of the final nucleotide of intron 15. To evaluate the functional activity of the G-CSF receptor with this 3-base pair deletion of the juxtamembrane region, we transfected this G-CSF receptor mutant into an interleukin 3-dependent cell line, BAF/3. BAF/3 cells expressing the mutant G-CSF receptor showed augmented proliferation activity in response to G-CSF compared with cells having the wild-type G-CSF receptor. Although the proliferation signal of G-CSF in normal hematopoiesis is transduced through the activation of MAP kinases, this G-CSF receptor mutant showed decreased activation of ERK1/2 in response to G-CSF compared with the wild type, but the transduced signal for Stat3 activation by G-CSF was of the same magnitude as that of the wild-type G-CSF receptor. This result means that the augmented proliferation activity in response to G-CSF that we observed in cells having the G-CSF receptor gene with the 3-base pair deletion is transduced through an intracellular signaling pathway other than MAP kinase. Because SCN patients with a mutation in the G-CSF receptor frequently develop leukemia, this 3-base pair deletion in the juxtamembrane sequence of the G-CSF receptor gene in this patient may be one step in the course of leukemic transformation.

AB - We analyzed the structure of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a 6-year-old female patient with severe congenital neutropenia (SCN) who experienced severe recurrent infections since 1 month of age. There is no family history of any similar disease. When the patient was 4 months old, she began receiving treatment with recombinant human G-CSF that resulted in a small increase in the neutrophil count sufficient for the prevention and treatment of bacterial infection. An analysis of complementary DNA for the patient's G-CSF receptor revealed a 3-base pair deletion in the juxtamembrane intracellular sequence. This deletion at the beginning of exon 16 was thought to be caused by alternative splicing; analysis of the DNA revealed a G-to-A point mutation of the final nucleotide of intron 15. To evaluate the functional activity of the G-CSF receptor with this 3-base pair deletion of the juxtamembrane region, we transfected this G-CSF receptor mutant into an interleukin 3-dependent cell line, BAF/3. BAF/3 cells expressing the mutant G-CSF receptor showed augmented proliferation activity in response to G-CSF compared with cells having the wild-type G-CSF receptor. Although the proliferation signal of G-CSF in normal hematopoiesis is transduced through the activation of MAP kinases, this G-CSF receptor mutant showed decreased activation of ERK1/2 in response to G-CSF compared with the wild type, but the transduced signal for Stat3 activation by G-CSF was of the same magnitude as that of the wild-type G-CSF receptor. This result means that the augmented proliferation activity in response to G-CSF that we observed in cells having the G-CSF receptor gene with the 3-base pair deletion is transduced through an intracellular signaling pathway other than MAP kinase. Because SCN patients with a mutation in the G-CSF receptor frequently develop leukemia, this 3-base pair deletion in the juxtamembrane sequence of the G-CSF receptor gene in this patient may be one step in the course of leukemic transformation.

UR - http://www.scopus.com/inward/record.url?scp=27244458913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27244458913&partnerID=8YFLogxK

U2 - 10.1532/IJH97.05010

DO - 10.1532/IJH97.05010

M3 - Article

VL - 82

SP - 28

EP - 34

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 1

ER -